Case of linear immunoglobulin A bullous dermatosis associated with acquired hemophilia

Journal of Dermatology

Volumn 35, Issue 7, 2008, Pages 437-446

  Arakaki, Osao ^a   Yamamoto, Yu Ichi ^a   Awazawa, Ryoko ^a   Nonaka, Kimiko ^a   Taira, Kiyohito ^a   Asato, Yutaka ^a   Hagiwara, Keisuke ^a,b   Oyama, Bungo ^c   Ishii, Norito ^c   Hashimoto, Takashi ^c   Uezato, Hiroshi ^a  

^a UNIVERSITY OF THE RYUKYUS   (Japan)

^b Chuo Dermatological Office   (Japan)

^c KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Acquired hemophilia; Ecchymosis; Hematoma; Linear immunoglobulin A bullous dermatosis; Purpura

Indexed keywords

BLOOD CLOTTING FACTOR 8; CORTICOSTEROID; DAPSONE; DIFLUPREDNATE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; PREDNISOLONE; RECOMBINANT BLOOD CLOTTING FACTOR 7A; VALACICLOVIR; VIDARABINE;

ACQUIRED HEMOPHILIA; AGED; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNE SKIN DISEASE; BASEMENT MEMBRANE ZONE; BLOOD TRANSFUSION; BULLOUS SKIN DISEASE; CASE REPORT; COLLAGEN DISEASE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ASSOCIATION; DISEASE COURSE; DRUG DOSE REDUCTION; DRUG EXPOSURE; ECCHYMOSIS; FEMALE; HEMOPHILIA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; INFECTION; LYMPHOPROLIFERATIVE DISEASE; MALIGNANT NEOPLASTIC DISEASE; NEOPLASM; PARTIAL THROMBOPLASTIN TIME; PEMPHIGUS; PSORIASIS; RHEUMATOID ARTHRITIS; SKIN BIOPSY; SKIN DISEASE; SKIN MANIFESTATION; TREATMENT RESPONSE;

AGED; AUTOIMMUNE DISEASES; FEMALE; HEMOPHILIA A; HUMANS; IMMUNOGLOBULIN A; SKIN DISEASES, VESICULOBULLOUS;

EID: 47149085263     PISSN: 03852407     EISSN: 13468138     Source Type: Journal    
DOI: 10.1111/j.1346-8138.2008.00499.x     Document Type: Article

References (53)

1. Zone JJ. Clinical spectrum, pathogenesis and treatment of linear IgA bullous dermatosis. J Dermatol 2001 28 : 651 653.
2. Green D, Lechner K. A survey of 215 non-hemophilic patients with inhibitors to Factor VIII. Thromb Haemost 1981 45 : 200 203.
3. Boggio LN, Green D. Acquired hemophilia. Rev Clin Exp Hematol 2001 5 : 389 404.
4. Delgado J, Jimenez-Yuste V, Hernandez-Navarro F, Villar A. Acquired haemophilia: review and meta-analysis focused on therapy and prognostic factors. Br J Haematol 2003 121 : 21 35.
5. Franchini M, Gandini G, Paolantonio T, Mariani G. Acquired hemophilia A: a concise review. Am J Hematol 2005 80 : 55 63.
6. Hultin MB. Acquired inhibitors in malignant and nonmalignant disease states. Am J Med 1991 91 : 9S 13S.
7. Bossi P, Cabane J, Ninet J et al. Acquired hemophilia due to factor VIII inhibitors in 34 patients. Am J Med 1998 105 : 400 408.
8. Chorzelski TP, Jablonska S, Beutner EH. Linear IgA bullous dermatosis. Adult form of linear IgA bullous dermatosis. In : Beutner EH, Chorzelski TP, Bean SF, eds. Immunopathology of the Skin. New York : Wiley, 1979 : 315 323.
9. Wojnarowska F, Marsden RA, Bhogal B, Black MM. Chronic bullous disease of childhood, childhood cicatricial pemphigoid, and linear IgA disease of adults. A comparative study demonstrating clinical and immunopathologic overlap. J Am Acad Dermatol 1988 19 : 792 805.
10. Dmochowski M, Hashimoto T, Bhogal BS, Black MM, Zone JJ, Nishikawa T : Immunoblotting studies of linear IgA disease. J Dermatol Sci 1993 6 : 194 200.
11. Guide SV, Marinkovich MP. Linear IgA bullous dermatosis. Clin Dermatol 2001 19 : 719 727.
12. Onodera H, Mihm Jr. MC, Yoshida A, Akasaka T : Drug-induced linear IgA bullous dermatosis. J Dermatol 2005 32 : 759 764.
13. Godfrey K, Wojnarowska F, Leonard J. Linear IgA disease of adults: association with lymphoproliferative malignancy and possible role of other triggering factors. Br J Dermatol 1990 123 : 447 52.
14. McEvoy MT, Connolly SM. Linear IgA dermatosis: association with malignancy. J Am Acad Dermatol 1990 22 : 59 63.
15. Cooke N, Jenkinson H, Wojnarowska F, McKenna K, Alderdice J. Coexistence of psoriasis and linear IgA disease in a patient with recent herpes zoster infection. Clin Exp Dermatol 2005 30 : 643 645.
16. Egan CA, Zone JJ. Linear IgA bullous dermatosis. Int J Dermatol. 1999 38 : 818 827.
17. Wojnarowska F. What's new in linear IgA disease? J Eur Acad Dermatol Venereol 2000 14 : 441 443.
18. Allen J, Wojnarowska F. Linear IgA disease: the IgA and IgG response to dermal to dermal antigens demonstrates a chiefly IgA response to LAD285 and a dermal 180-kDa protein. Br J Dermatol 2003 149 : 1055 1058.
19. Sohngen D, Specker C, Bach D et al. Acquired factor VIII inhibitors in nonhemophilic patients. Ann Hematol 1997 74 : 89 93.
20. Collins P, Macartney N, Davies R, Lees S, Giddings J, Majer R. A population based, unselected, consecutive cohort of patients with acquired haemophilia A. Br J Haematol 2004 124 : 86 90.
21. Hay CR, Brown S, Collins PW, Keeling DM, Liesner R. The diagnosis and management of factor VIII and IX inhibitors: a guideline from the United Kingdom Haemophilia Centre Doctors Organisation. Br J Haematol 2006 133 : 591 605.
22. Yee TT, Taher A, Pasi KJ, Lee CA. A survey of patients with acquired haemophilia in a haemophilia centre over a 28-year period. Clin Lab Haematol 2000 22 : 275 278.
23. Huang YW, Saidi P, Philipp C. Acquired factor VIII inhibitors in non-haemophilic patients: clinical experience of 15 cases. Haemophilia 2004 10 : 713 721.
24. Shima M. Characterization of factor VIII inhibitors. Int J Hematol 2006 83 : 109 18.
25. Bouvry P, Recloux P. Acquired hemophilia. Haematologica 1994 79 : 550 556.
26. Cohen AJ, Kessler CM. Acquired inhibitors. Baillieres Clin Haematol 1996 9 : 331 354.
27. Solymoss S. Postpartum acquired factor VIII inhibitors: results of a survey. Am J Hematol 1998 59 : 1 4.
28. Sallah S, Wan JY. Inhibitors against factor VIII in patients with cancer. Analysis of 41 patients. Cancer 2001 91 : 1067 1074.
29. Sallah S. Treatment of acquired haemophilia with factor eight inhibitor bypassing activity. Haemophilia 2004 10 : 169 173.
30. Holme PA, Brosstad F, Tjonnfjord GE. Acquired haemophilia: management of bleeds and immune therapy to eradicate autoantibodies. Haemophilia 2005 11 : 510 515.
31. Takada M, Tsukada M, Shinonome M et al. [A case of pemphigus vulgaris with occurrence of a factor VIII inhibitor successfully treated with plasma exchange.] Jpn J Clin Hematol 1981 22 : 1605 1610. (In Japanese.)
32. Ishikawa O, Tamura A, Ohnishi K, Miyachi Y. Pemphigus vulgaris associated with acquired hemophilia A due to factor VIII inhibitor. Acta Derm Venereol 1993 73 : 229 230.
33. Tobita Y, Yamamoto T, Nishioka S, Takisita Y, Yoneda K. [A case of pemphigus vulgaris with occurrence of acquired factor VIII inhibitors.] Nishinihon J Dermatol 1998 60 : 715. (In Japanese.)
34. Reimer G, Link I, Hauck H. Senear-Usher syndrome: acquired hemophilia caused by the occurrence of a factor VIII inhibitor. Hautarzt 1982 33 : 645 648.
35. Fischer M, Lechner K, Raith W. Inhibitor hemophilia in bullous pemphigoid (Lever). Hautarzt 1968 19 : 459 462.
36. Nishimura Y, Sanada I, Hujiwara K et al. [A case of bullous pemphigoid with the occurrence of a factor VIII inhibitor.] Journal of Japan Society of Blood Transfusion 1985 30 : 212 213. (In Japanese.)
37. Shiono M, Hayashi K, Honda C et al. Bullous pemphigoid with acquired Factor VIII inhibitor: a review of acquired factor VIII inhibitor. Rinsyo Hihu 1991 45 : 925 929. (In Japanese.)
38. Morrison AE, Ludlam CA, Kessler C. Use of porcine factor VIII in the treatment of patients with acquired hemophilia. Blood 1993 81 : 1513 1520.
39. Ando T, Shinohara K, Nomiyama J, Toyosawa M, Inoue H. A case of acquired coagulation disorder caused by inhibitor against factor V and VIII associated with bullous pemphigoid. Jpn Arch Int Med 1994 41 : 205 210.
40. Biron C, Durand L, Lemkecher T et al. Simultaneous occurrence of lupus anticoagulant, factor VIII inhibitor and localized pemphigoid. Am J Hematol 1996 51 : 250 251.
41. Kuboki T, Kudo T, Iwata N, Morimoto I. Recurrent bleeding tendency due to factor VIII inhibitor during therapy for bullous pemphigoid. Jpn J Clin Hematol 1999 40 : 1087 1091. (In Japanese.)
42. Lightburn E, Morand JJ, Graffin B et al. Pemphigoid and acquired hemophilia. Ann Dermatol Venereol 2001 128 : 1229 1231.
43. Maczek C, Thoma-Uszynski S, Schuler G, Hertl M. Simultaneous onset of pemphigoid and factor VIII antibody hemophilia. Hautarzt 2002 53 : 412 415.
44. Patel RS, Harman KE, Nichols C, Burd RM, Pavord S. Acquired haemophilia heralded by bleeding into the oral mucosa in a patient with bullous pemphigoid, rheumatoid arthritis, and vitiligo. Postgrad Med J 2006 82 : e3.
45. Hurley D, Boyd JH, Eby C. Laryngeal epidermolysis bullosa acquisita requiring tracheostomy presenting with an acquired factor VIII coagulopathy. Otolaryngol Head Neck Surg 2001 125 : 270 271.
46. Nagano T, Tani M, Hiramatsu Y et al. A case of epidermolysis bullosa acquisita with bleeding tendency due to factor VIII inhibitor (acquired haemophilia). Br J Dermatol 2004 151 : 716 717.
47. Maize JC Jr, Cohen JB. Cyclosporine controls epidermolysis bullosa acquisita co-occurring with acquired factor VIII deficiency. Int J Dermatol 2005 44 : 692 694.
48. Ly A, Roth B, Causeret AS et al. Anti-laminin 5 pemphigoid and acquired haemophilia. Br J Dermatol 2002 146 : 1104 1105.
49. Leebeek FW, Kappers-Klunne MC, Jie KS. Effective and safe use of recombinant factor VIIa (NovoSeven) in elderly mild haemophilia A patients with high-titre antibodies against factor VIII. Haemophilia 2004 10 : 250 253.
50. Ma AD, Carrizosa D. Acquired factor VIII inhibitors: pathophysiology and treatment. Hematology Am Soc Hematol Educ Program 2006 432 437.
51. Au WY, Lam CC, Kwong YL. Successful treatment of acquired factor VIII inhibitor with cyclosporin. Haemophilia 2004 10 : 98 100.
52. Wiestner A, Cho HJ, Asch AS et al. Rituximab in the treatment of acquired factor VIII inhibitors. Blood 2002 100 : 3426 3428.
53. Stasi R, Brunetti M, Stipa E, Amadori S. Selective B-cell depletion with rituximab for the treatment of patients with acquired hemophilia. Blood 2004 103 : 4424 4428.